Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2007
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282500 Nitrogen compounds such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic Acid (2-morpholin-4-yl-ethyl)-amide, used as anticarcinogenic agents and for prophylaxis of brain disorders
10/16/2007US7282499 4,5,6,7-tetrahydro-4-(2-(morpholin-4-yl)ethyl)-1-phenyl-1H-indazole oxalate; N-benzyl-2-(1-(4-fluorophenyl)-4,5,6,7-tetrahydro-1H-indazol-4-yl)-N-methyl-ethanamine; therapeutical, prophylaxis, psychosis or pain
10/16/2007US7282498 Substituted fused pyrroleoximes and fused pyrazoleoximes
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/11/2007WO2007114326A1 Novel compound having heterocyclic ring
10/11/2007WO2007114323A1 Aminopyrrolidine compound
10/11/2007WO2007114124A1 ISOXAZOLE DERIVATIVE AND ISOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11β-HYDROXYSTEROID DEHYDROGENASE TYPE I
10/11/2007WO2007113634A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007WO2007113261A1 Process for preparing heterocyclic derivatives
10/11/2007WO2007113232A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2006094763A8 3,4,5-substituted piperidine compounds
10/11/2007US20070238765 Heterocyclic GABAA subtype selective receptor modulators
10/11/2007US20070238736 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-[4-(Benzo [1,3]dioxole-5-carbonyl)-piperazin-1-yl]-1-(4-fluoro-benzyl)-2-oxo-1,2-dihydro-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238731 Dna-Pk Inhibitors
10/11/2007US20070238729 Dna-pk inhibitors
10/11/2007US20070238727 5-Substituted 1-Phenyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones and Analogs as Anti-Virals
10/11/2007US20070238723 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
10/11/2007US20070238721 Highly Selective Novel Amidation Method
10/11/2007CA2682846A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007CA2648089A1 Process for preparing heterocyclic derivatives
10/11/2007CA2648087A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007CA2647605A1 Novel compound having heterocyclic ring
10/10/2007EP1842556A1 Therapeutic agent for attention-deficit hyperactivity disorder
10/10/2007EP1841770A2 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/10/2007EP1841762A1 Substituted indoles, compositions containing them, method for the production thereof and their use
10/10/2007EP1841760A2 Pyrimidine derivatives as kinase modulators and method of use
10/10/2007EP1841757A2 Heteroaromatic quinoline compounds and their use as pde10 inhibitors
10/10/2007EP1841756A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841755A1 Substituted indole ligands for the orl-1 receptor
10/10/2007EP1841741A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
10/10/2007EP1841737A1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
10/10/2007EP1841504A2 Substituted biaryl compounds as factor xia inhibitors
10/10/2007EP1581515B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1379525B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007CN101052628A Isoxazolines derivatives and its weedicide application
10/10/2007CN101052301A (hetero) cyclylcarboxamide for preventing and controlling pathogenic fungi
10/09/2007US7279586 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279494 For therapy of bacterial infections; such as N-[((5S)-3-{3-fluoro-4-[exo-(1R,5S)-3-thiabicyclo[3.1.0]hex-6-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]acetamide
10/09/2007US7279491 Phenylpiperidines and phenylpyrrolidines
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279481 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone; therapy of depression or anxiety
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279475 Cytokine inhibitors, useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease; for example, 1-(2-methoxy-5-trifluoromethyl-phenyl)-3-{4-[6-methyl-2-(2-morpholin-4-yl-ethyl)-pyrimidin-4-yloxy]-naphthalen-1-yl}-urea
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279471 Butane-1,4-diones 1-substituted by a phenyltriazonylpiperidinyl- or benzo-1,3-diazepinonylpiperidinyl- group, e.g., (1) 1-(1,4'-bipiperidinyl-1'-yl)-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5,-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butane-1,4-dione; treating headaches, diabetes
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279469 Diaminotriazoles useful as inhibitors of protein kinases
10/09/2007US7279467 Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors
10/09/2007US7279444 for controlling undesirable plants
10/09/2007CA2161857C Oxazolidinone derivatives as adhesion receptor antagonists
10/04/2007WO2007112322A2 Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
10/04/2007WO2007111323A1 Ureide derivative and use thereof for medical purposes
10/04/2007WO2007111212A1 Triazolone derivative
10/04/2007WO2007111179A1 Diagnostic imaging agent for incurable neuron disease
10/04/2007WO2007110727A2 Amide stabilized hydroxyethylamines
10/04/2007WO2007110418A2 Substituted 5-hetaryl-4-aminopyrimidines
10/04/2007WO2007110374A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/04/2007WO2007110364A1 Benzothiazoles having histamine h3 receptor activity
10/04/2007WO2007110337A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007WO2007110214A1 12-aza-ep0thil0nes, process for their preparation and their use as antiproliferative agents
10/04/2007WO2007072164A3 Estrogen modulators
10/04/2007US20070232684 Compounds for inhibition of HIV infection by blocking HIV entry
10/04/2007US20070232659 Novel Alkyl Substituted Piperidine Derivatives as Monoamine Neurotransmitter Re-Uptake Inhibitors
10/04/2007US20070232620 N-3-chlorobenzyl-3-amino-1H-indazole-5-carboxamide; 3-aminoindazoles; glucocorticoid-depedent kinase (SGK) inhibitors; SGK-induced diseases; diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, fibrosis; inflammatory agents
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232607 Quinazoline Derivatives as Erbb Receptor Tyrosine kinases
10/04/2007US20070232606 Compounds and Compositions as Cathepsin S Inhibitors
10/04/2007US20070232605 Inhibitors of soluble adenylate cyclase
10/04/2007US20070232603 Small-molecule modulators of TRP-P8 activity
10/04/2007US20070232602 Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232594 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both
10/04/2007US20070232590 3-Cylcoalkylbenzazepines as Histamine H3 Antagonists
10/04/2007US20070231821 Methods and compositions for detecting polynucleotides
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007CA2680789A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/04/2007CA2647603A1 Ureide derivative and use thereof for medical purposes
10/04/2007CA2647423A1 Triazolone derivative
10/04/2007CA2647252A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/04/2007CA2647163A1 Modified macrophage migration inhibitory factor inhibitors
10/04/2007CA2646732A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007CA2645779A1 Substituted 5-hetaryl-4-aminopyrimidines
10/04/2007CA2645581A1 Benzothiazoles having histamine h3 receptor activity
10/04/2007CA2644369A1 Amide derivatives and their application for the treatment of g protein related diseases
10/03/2007EP1840126A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same
10/03/2007EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
10/03/2007EP1840123A1 Isoxazolines and their use as inhibitors of phosphodiesterase type-IV
1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 647